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Fructose consumption in the USA has increased over the past three decades. During this time, obesity, insulin resistance and the metabolic syn-
drome have also increased in prevalence. While diets high in fructose have been shown to promote insulin resistance and increase TAG concen-
trations in animals, there are insufficient data available regarding the long-term metabolic effects of fructose consumption in humans. The
objective of the present study was to investigate the metabolic effects of 10-week consumption of fructose-sweetened beverages in human subjects
under energy-balanced conditions in a controlled research setting. Following a 4-week weight-maintaining complex carbohydrate diet, seven over-
weight or obese (BMI 26·8–33·3 kg/m2) postmenopausal women were fed an isoenergetic intervention diet, which included a fructose-sweetened
beverage with each meal, for 10 weeks. The intervention diet provided 15% of energy from protein, 30% from fat and 55% from carbohydrate
(30% complex carbohydrate, 25% fructose). Fasting and postprandial glucose, insulin, TAG and apoB concentrations were measured. Fructose
consumption increased fasting glucose concentrations and decreased meal-associated glucose and insulin responses (P¼0·0002, P¼0·007 and
P¼0·013, respectively). Moreover, after 10 weeks of fructose consumption, 14 h postprandial TAG profiles were significantly increased, with
the area under the curve at 10 weeks being 141% higher than at baseline (P¼0·04). Fructose also increased fasting apoB concentrations by
19% (P¼0·043 v. baseline). In summary, consumption of fructose-sweetened beverages increased postprandial TAG and fasting apoB concen-
trations, and the present results suggest that long-term consumption of diets high in fructose could lead to an increased risk of CVD.
Fructose: Glucose: Insulin: Hypertriacylglycerolaemia: Apolipoprotein-B
Dietary fructose consumption in the USA has increased by
about 30% during the past three decades(1) and has coincided
with a dramatic rise in the prevalence of obesity and its meta-
bolic consequences(2,3). There is substantial evidence from
studies conducted in animals and some in human subjects to
indicate that high-fructose diets can promote the development
of the metabolic syndrome(1,3,4). Fructose is primarily meta-
bolised by the liver, where it is a highly lipogenic substrate(5).
In animals, fructose consumption enhances hepatic de novo
lipogenesis(6) and increases the secretion of apoB-containing
VLDL particles(7). Similarly, in humans, consumption of a
high-fructose diet can increase both fasting(8) and postpran-
dial(9) plasma TAG concentrations relative to diets containing
starch or glucose. High-fructose diets can promote insulin
resistance in animals by directly interfering with hepatic
insulin signalling(10–12); and the elevated postprandial TAG
in response to fructose may further impair insulin sensi-
tivity(13). Consistent with these effects, overfeeding human
subjects with a high-fructose diet for 6 d not only led to
increased de novo lipogenesis and plasma TAG, but also
reduced hepatic insulin sensitivity(14).
Unlike glucose, fructose does not stimulate insulin
secretion, due to its hepatic metabolism and the low level of
expression of the fructose transporter GLUT5 in pancreatic
b-cells(15). The metabolic effects of long-term consumption
of high-fructose diets have not been fully investigated in
human subjects. In a short-term study in normal-weight
women, we reported that consumption of fructose-sweetened
beverages (providing 30% of total energy) with meals resulted
in lowered postprandial glucose and insulin excursions,
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reduced 24 h circulating leptin concentrations relative to when
the subjects consumed glucose-sweetened beverages, and pro-
duced sustained increases of postprandial plasma TAG(16).
The present study was designed to investigate the effects of
an isoenergetic 10-week intervention, in which 25% of daily
energy requirements was provided as fructose-sweetened
beverages, on fasting and postprandial glucose, insulin, TAG
and plasma apoB concentrations.
Subjects and methods
Subjects
Seven overweight or obese (BMI 26·8–33·3 kg/m2) postmeno-
pausalwomen (age 50–72years)were recruited.All subjects pro-
vided informed consent to participate in the study, and reported
being non-smokers, relatively sedentary and weight stable.
Subjects were given a complete medical examination.
Experimental protocol
The experimental protocol was approved by the Human Sub-
jects Review Committee at the University of California
(Davis, CA, USA). Subjects resided in a residential facility
during the entire 14-week period, where body weight, food
intake and blood pressure were monitored. Body composition
measurements and 14 h postprandial blood collections were
performed at the Ragle Human Nutrition Research Facility
(University of California, Davis, CA, USA). Exercise was
limited to three supervised 20min walks per week.
Subjects were studied at three different times; at the end of a
4-week baseline period (before dietary intervention) and at 2 and
10 weeks during the intervention. During the initial baseline
period, subjects consumed a weight-maintaining diet. Energy
requirements for weight maintenance were estimated using
the Harris–Benedict equation(17) and with a physical activity
factor of 1·5(18). Subjects were weighed daily, and energy
intake was adjusted every fourth day to maintain body
weight. Following this stabilisation period, subjects were fed
100% of their established energy requirements. Body compo-
sition was determined by dual-energy X-ray absorptiometry
(Lunar DPX; Lunar Corp., Madison, WI, USA).
Diets
Diets provided 15% of energy from protein, 30% from fat and
55% from carbohydrate. During the baseline period, the
carbohydrate was composed almost entirely of complex carbo-
hydrate (i.e. starches from bread, rice and pasta), and the fruc-
tose content was , 3%. During intervention, complex
carbohydrate was replaced with beverages sweetened with
free fructose (at 25% of daily energy requirements), while
the protein and fat content of the diet were unchanged.
Beverages were prepared as 12% (w/w) solutions, flavoured
with a popular unsweetened drink mix. The diets provided
about 20 g dietary fibre per d.
The meals consisted of a 5 d rotating menu, served as three
meals (breakfast at 09.00 hours, lunch at 13.00 hours, dinner at
18.00 hours) and a snack (at 21.00 hours). The subjects con-
sumed all food provided. On each test day, a specific
(sixth) menu was served to standardise test diet conditions.
Prepared lunch and dinner items were obtained from Life
Spring (Richmond, CA, USA).
Blood sampling
Blood samples were collected between 08.00 and 22.00 hours,
at 30min intervals around meal ingestion and at hourly inter-
vals at other times. At each collection time, 4ml blood was
obtained and placed into tubes containing EDTA. Samples
were stored on ice, centrifuged, and stored at 2808C before
assay. Full postprandial profiles were not obtained in all sub-
jects due to inadequate patency of intravenous catheters in
two subjects. Thus, the area-under-the-curve data for the 14 h
profiles represent five subjects consuming fructose.
Assays
Fasting serum lipids (total cholesterol, LDL- and HDL-choles-
terol and TAG) were determined with a Beckman Coulter
Synchron LX (Fullerton, CA, USA). Fasting apoB was
measured in the 08.00 hours sample, as described(19).
Plasma glucose was measured with a YSI 2300 Glucose
Analyser (Yellow Springs Instruments, Yellow Springs, OH,
USA). Plasma insulin was measured by RIA using 125I
human insulin (Amersham, Piscataway, NJ, USA) and
human insulin standards from Linco Research (St Charles,
MO, USA). Homeostatic model assessment of insulin resis-
tance was calculated as described(20).
Data analysis
Fasting concentrations of glucose, insulin and TAG were
determined as the average of the first three measurements
(08.00 hours, 08.30 hours and 09.00 hours). Areas under the
curve for glucose, insulin and TAG were calculated by the tra-
pezoidal method using Microsoft Excel. Statistical analysis
was performed with Prism 2.01 (GraphPad Software, San
Diego, CA, USA). The significance of changes of parameters
between baseline and 2 and 10 weeks of dietary intervention
was determined by one-way repeated-measures ANOVA.
The difference in apoB concentrations at 10 weeks was
assessed by the paired t test. The two-sided level of signifi-
cance was set at P,0·05.
Results
Body weight, body composition and blood pressure
There was a small (about 1·5%) decrease of body weight over
the 10-week intervention period (Table 1). Body composition
was not significantly changed, and blood pressure remained
stable over the 10-week intervention.
Fasting plasma concentrations of glucose, insulin and lipids
Consumption of the fructose-sweetened beverages signifi-
cantly increased fasting glucose concentrations at 2 weeks
and 10 weeks (P¼0·0002 v. baseline) (Table 1). Fasting
plasma insulin concentrations and homeostatic model assess-
ment of insulin resistance were not significantly increased.
There were no significant effects of fructose consumption on
fasting total cholesterol, LDL, HDL or plasma TAG concen-
trations (Table 1).
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Postprandial glucose, insulin and triacylglycerol responses
and fasting apolipoprotein-B concentrations
Consumption of fructose reduced meal-related plasma
glucose excursions by 67% at 2 weeks and by 73% at 10
weeks (Fig. 1 (a)). The insulin area under the curve was reduced
in subjects consuming fructose-sweetened beverages, by 42%at
2 weeks and 39% at 10 weeks, relative to baseline (Fig. 1 (b)).
Relative to the baseline diet, consumption of fructose-swee-
tened beverages resulted in a progressive increase of postpran-
dial TAG concentrations. The TAG area under the curve was
increased by 44% after 2 weeks and by 141% at 10 weeks in
the subjects consuming fructose (Fig. 1 (c)). After 10 weeks of
fructose consumption, fasting apoB concentrations increased
by 19·3 (SE 7·8) % (P¼0·043; Fig. 1 (d)). In four subjects
who underwent the same protocol, but consumed glucose-
sweetened beverages for 10 weeks, no increases of postpran-
dial TAG profiles or fasting apoB concentrations were
observed (data not shown).
Discussion
In the present study, we investigated the effects of consuming
fructose-sweetened beverages (25% of energy requirements)
for 10 weeks on circulating glucose, insulin, TAG and apoB
concentrations in overweight or obese postmenopausal
women. Compared with a diet high in complex carbohydrates,
consumption of fructose-sweetened beverages as part of an
isoenergetic diet increased fasting plasma glucose concen-
trations, reduced meal-induced glucose and insulin excursions,
and increased postprandial TAG concentrations and fasting
plasma apoB concentrations.
A major strength of the present study is the high degree of
control over the subjects’ diets, with the subjects residing in a
supervised setting and consuming standardised meals for the
entire 14-week period. Another strength of the present study
is that in addition to fasting concentrations, postprandial glu-
cose, insulin and TAG responses were measured. Examination
of only the fasting concentrations would not have revealed the
marked effects of fructose consumption on postprandial TAG
profiles. Subjects consuming the fructose-sweetened beverages
for 10 weeks exhibited increased circulating TAG concen-
trations of . 1mmol/l over fasting concentrations for the
entire period from after lunch until 22.00 hours in the evening
(Fig. 1 (c)). A number of studies support the existence of an
independent relationship between non-fasting (postprandial)
TAG concentrations and CVD(21,22). Moreover, because circu-
lating apoB concentrations reflect the total number of poten-
tially atherogenic lipoprotein particles, the increase of apoB
concentrations observed here suggests that long-term con-
sumption of high amounts of fructose could be atherogenic(23).
The main limitations of the present study are that the obser-
vations were restricted to overweight, postmenopausal
women. Due to the high cost of the study, enrolment was limi-
ted to postmenopausal women, in order to avoid the possible
confounding effects of age, sex and menstrual cycle on post-
prandial TAG metabolism(24,25).
The finding that consuming fructose-sweetened beverages
promotes postprandial hypertriacylglycerolaemia is well sup-
ported by studies in animals fed high-fructose diets(1), and by
several studies in human subjects, although there are some con-
flicting results in the literature(2). While the precise biochemical
mechanisms underlying fructose-induced hepatic VLDL over-
production are unknown, studies in mice have shown that
Table 1. Anthropometric, biochemical and postprandial measurements of subjects consuming fructose-sweetened beverages at 25 % of daily energy
requirements for 10 weeks†
(Mean values with their standard errors)
Baseline 2 weeks 10 weeks
Variables Mean SE Mean SE Mean SE P
Anthropometric measurements
Body weight (kg) 75·7 9·2 75·3 9·2 74·6** 9·6 0·016
BMI (kg/m2) 29·1 2·2 29·0 2·1 28·7** 2·4 0·011
Body fat (%) 49·2 2·7 49·4 3·0 49·1 2·9 0·64
Fat mass (kg) 37·2 5·0 37·2 5·3 36·7 5·3 0·097
Lean mass (kg) 38·5 5·0 38·1 4·8 37·9 5·2 0·30‡
SBP (mmHg) 130 14 128 7 133 14 0·52
DBP (mmHg) 70 12 69 8 69 12 0·67
Biochemical measurements
Fasting glucose (mmol/l) 4·6 0·4 4·9*** 0·4 4·9*** 0·4 0·0002
Fasting insulin (pmol/l) 58 18 68 26 62 27 0·32
HOMA-IR 1·71 0·61 2·13 0·80 1·96 0·91 0·15
Total cholesterol (mmol/l) 4·99 1·26 5·15 0·92 4·76 0·99 0·11
HDL-cholesterol (mmol/l) 1·07 0·29 1·13 0·23 1·04 0·27 0·51
LDL-cholesterol (mmol/l) 2·90 0·89 2·95 0·95 2·72 1·04 0·26
TAG (mmol/l) 1·69 1·30 1·93 1·98 1·93 2·49 0·49‡
Postprandial measurements
Glucose AUC (mmol/l £ 14 h) 15·4 3·4 5·2** 2·3 4·9** 2·1 0·007
Insulin AUC (pmol/l £ 14 h) 3229 611 2014* 410 2132* 306 0·013
TAG AUC (mmol/l £ 14 h) 5·1 2·5 7·3 1·8 12·3* 2·5 0·040
SBP, systolic blood pressure; DBP, diastolic blood pressure; HOMA-IR, homeostatic model assessment of insulin resistance; AUC, area under the curve.
Mean value was significantly different from that at baseline: *P,0·05, **P,0·01, ***P,0·001.
† For details of subjects and procedures, see Subjects and methods.
‡ The Friedman test was used.
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long-term fructose feeding induces the hepatic expression of a
number of lipogenic genes, including stearoyl-CoA desatur-
ase(26). Other rodent studies indicate that protein tyrosine phos-
phatase-1B, a negative regulator of insulin signalling, is required
for fructose-associated increases in VLDL secretion(27).
Impaired TAG uptake by adipose tissue, possibly due to reduced
adipose tissue lipoprotein lipase activation from the lower insu-
lin excursions, may also contribute to fructose-induced hyper-
triacylglycerolaemia in humans(28). In the present study, the
relative contributions of increased TAG production v. reduced
clearance were not examined; however, this issue is currently
being addressed in our ongoing studies.
In human subjects, several short-term studies indicate that
fructose consumption induces postprandial hypertriacylglycer-
olaemia(29–31). In our previous study, consumption of
fructose-sweetened beverages (30% of energy) with mixed-
nutrient meals in normal-weight women led to a rapid and
prolonged increase of plasma TAG concentrations compared
with when the same subjects consumed an equal amount of
glucose(16). We have obtained similar results in overweight
and obese men and women(32).
Bantle et al. fed men and women diets containing 17% of
energy as either fructose or glucose for 6 weeks(9). Men on
the fructose diet had significantly higher fasting plasma
TAG concentrations and 24 h circulating TAG responses
than the men consuming glucose, but neither of these effects
were observed in women. The lack of an observable effect
of fructose on postprandial TAG concentrations in women
may be due to differences in age between the women in pre-
sent study (mean age 64 (SE 3) years) and those studied by
Bantle et al. (9) (overall mean about 40 years). Postprandial
TAG responses are known to be greater in older subjects(24).
Other factors, such as the presence of obesity and/or insulin
resistance, the amount of fructose included in the diet, and
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Fig. 1. Changes of plasma glucose (a), insulin (b) and TAG (c) over the three 14 h sampling periods during which subjects consumed either a high-complex
carbohydrate diet (0 weeks; –W–) or an isoenergetic diet with fructose-sweetened beverages at 25 % of daily energy requirements (2 weeks (- -X- -) and 10
weeks (- -K- -)). Fasting apoB concentrations at 0 and 10 weeks of fructose beverage consumption are shown in (d). Values are means, with standard errors rep-
resented by vertical bars. * Mean value was significantly different from that at week 0 (P,0·05).
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the use of in-patient v. out-patient studies may also explain the
inconsistencies that have been observed between studies. The
effects of fructose consumption on postprandial TAG may also
be exacerbated by pre-existing hypertriacylglycerolaemia and
hyperinsulinaemia(33,34). Study duration may also be an
important factor for the development of postprandial hyper-
triacylglycerolaemia, as it was much more pronounced after
10 weeks of fructose consumption than at 2 weeks.
Drinking fructose-sweetened beverages as part of a
weight-maintaining diet also increased fasting plasma glucose
concentrations, while meal-related excursions of plasma glu-
cose and insulin were reduced. These findings are consistent
with our short-term results(16) and some(35), but not all, studies
of human subjects(2). Increases of fasting plasma glucose con-
centrations, within the normoglycaemic range, have been
reported to independently predict the development of type 2
diabetes in men(36).
The amount of added fructose (25% of energy) investigated
here is higher than the average US daily consumption, as the
most recent estimate for the mean intake of added sugars by
Americans (the 1994–6 Continuing Survey of Food Intakes
by Individuals(37)) was 15·8%. It is likely, however, that
intake of sugar-sweetened beverages as well as total energy
intake has increased in the 12 years since this survey, and is
likely to be higher in certain groups, such as adolescents(38).
Moreover, as sugar, fat and energy consumption are often
under-reported in surveys(39), we propose that consuming
25% of total energy as sugars is not uncommon. However,
since high-fructose corn syrup and sucrose are the predominant
sweetners in the US food supply and are composed of approxi-
mately equal parts fructose and glucose, it is unlikely that fruc-
tose itself is often consumed at 25% of total energy.
Interestingly, we have preliminary data which demonstrate
that high-fructose corn syrup and sucrose both increase post-
prandial TAG comparably to pure fructose alone, and to support
the relationship between fructose consumption and elevated
postprandial TAG and apoB concentrations in a larger group
of overweight and obese male and female subjects (n 18)(40).
In summary, consumption of fructose-sweetened beverages
as part of a weight-maintaining diet for 10 weeks increased fast-
ing glucose concentrations, postprandial TAG concentrations,
as well as fasting plasma apoB concentrations in overweight
and obese postmenopausal women. Together, these results
suggest that obtaining a significant proportion of daily energy
intake from fructose may promote or exacerbate altered lipid
and carbohydrate metabolism associated with the metabolic
syndrome, the prevalence of which has increased dramatically
in parallel with fructose consumption in the USA. Furthermore,
the increased fasting apoB and postprandial TAG concen-
trations observed in response to fructose consumption suggest
that prolonged consumption of diets high in fructose could con-
tribute to an increased risk for development of CVD.
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